Identifying the Best Machine Learning Algorithms for Brain Tumor Segmentation, Progression Assessment, and Overall Survival Prediction in the BRATS Challenge
Authors:
Spyridon Bakas,
Mauricio Reyes,
Andras Jakab,
Stefan Bauer,
Markus Rempfler,
Alessandro Crimi,
Russell Takeshi Shinohara,
Christoph Berger,
Sung Min Ha,
Martin Rozycki,
Marcel Prastawa,
Esther Alberts,
Jana Lipkova,
John Freymann,
Justin Kirby,
Michel Bilello,
Hassan Fathallah-Shaykh,
Roland Wiest,
Jan Kirschke,
Benedikt Wiestler,
Rivka Colen,
Aikaterini Kotrotsou,
Pamela Lamontagne,
Daniel Marcus,
Mikhail Milchenko
, et al. (402 additional authors not shown)
Abstract:
Gliomas are the most common primary brain malignancies, with different degrees of aggressiveness, variable prognosis and various heterogeneous histologic sub-regions, i.e., peritumoral edematous/invaded tissue, necrotic core, active and non-enhancing core. This intrinsic heterogeneity is also portrayed in their radio-phenotype, as their sub-regions are depicted by varying intensity profiles dissem…
▽ More
Gliomas are the most common primary brain malignancies, with different degrees of aggressiveness, variable prognosis and various heterogeneous histologic sub-regions, i.e., peritumoral edematous/invaded tissue, necrotic core, active and non-enhancing core. This intrinsic heterogeneity is also portrayed in their radio-phenotype, as their sub-regions are depicted by varying intensity profiles disseminated across multi-parametric magnetic resonance imaging (mpMRI) scans, reflecting varying biological properties. Their heterogeneous shape, extent, and location are some of the factors that make these tumors difficult to resect, and in some cases inoperable. The amount of resected tumor is a factor also considered in longitudinal scans, when evaluating the apparent tumor for potential diagnosis of progression. Furthermore, there is mounting evidence that accurate segmentation of the various tumor sub-regions can offer the basis for quantitative image analysis towards prediction of patient overall survival. This study assesses the state-of-the-art machine learning (ML) methods used for brain tumor image analysis in mpMRI scans, during the last seven instances of the International Brain Tumor Segmentation (BraTS) challenge, i.e., 2012-2018. Specifically, we focus on i) evaluating segmentations of the various glioma sub-regions in pre-operative mpMRI scans, ii) assessing potential tumor progression by virtue of longitudinal growth of tumor sub-regions, beyond use of the RECIST/RANO criteria, and iii) predicting the overall survival from pre-operative mpMRI scans of patients that underwent gross total resection. Finally, we investigate the challenge of identifying the best ML algorithms for each of these tasks, considering that apart from being diverse on each instance of the challenge, the multi-institutional mpMRI BraTS dataset has also been a continuously evolving/growing dataset.
△ Less
Submitted 23 April, 2019; v1 submitted 5 November, 2018;
originally announced November 2018.
Generative Adversarial Networks for Electronic Health Records: A Framework for Exploring and Evaluating Methods for Predicting Drug-Induced Laboratory Test Trajectories
Authors:
Alexandre Yahi,
Rami Vanguri,
Noémie Elhadad,
Nicholas P. Tatonetti
Abstract:
Generative Adversarial Networks (GANs) represent a promising class of generative networks that combine neural networks with game theory. From generating realistic images and videos to assisting musical creation, GANs are transforming many fields of arts and sciences. However, their application to healthcare has not been fully realized, more specifically in generating electronic health records (EHR…
▽ More
Generative Adversarial Networks (GANs) represent a promising class of generative networks that combine neural networks with game theory. From generating realistic images and videos to assisting musical creation, GANs are transforming many fields of arts and sciences. However, their application to healthcare has not been fully realized, more specifically in generating electronic health records (EHR) data. In this paper, we propose a framework for exploring the value of GANs in the context of continuous laboratory time series data. We devise an unsupervised evaluation method that measures the predictive power of synthetic laboratory test time series. Further, we show that when it comes to predicting the impact of drug exposure on laboratory test data, incorporating representation learning of the training cohorts prior to training GAN models is beneficial.
△ Less
Submitted 30 November, 2017;
originally announced December 2017.
